10.1097/BOR.0000000000000254
Goh discussed hair loss management for ACD and massive weight loss following use of injectable medications at the California Society of Dermatology and Dermatologic Surgery (CalDerm) and the Pacific Dermatologic Association (PDA) in San Diego, CA
If youre ready to start treatment, there are steps you can take to determine whether your GLP-1 medications will be covered
Step 9: Prepare and inject The injection technique from here is identical to the pen method
tirzepatide: Mechanisms of action Both retatrutide and tirzepatide help control blood sugar and aid in weight loss, but they work in slightly different ways: Tirzepatide : Tirzepatide works by activating the GLP-1 and GIP receptors in the body, helping to control blood sugar, reduce appetite, and make you feel fuller for longer, even with less food
2027 Capturing the impact of Facioscapulohumeral Muscular Dystrophy (FSHD) on Health-related Quality of Life (HRQoL): a systematic review of the reliability and validity of existing self-report instruments using COSMIN Jill Carlton 1 , Philip Powell 1 , S Frances 1 , Claire Williams 1 , Anthea Sutton 1 , Jonathan Street 1 , Channa Hewamadduma 1 , Jill Carlton 1 1 University of Sheffield, Sheffield, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2027 Aims Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle wasting condition causing progressive weakness